Examination of the ability for the treatment of 5-ALA for patients with oligozoospermia and asthenozoospermia

Examination of the ability for the treatment of 5-ALA for patients with oligozoospermia and asthenozoospermia - Examination of the ability for the treatment of 5-ALA for patients with oligozoospermia and asthenozoospermia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028541

Enrollment

Registered

2017-08-04

Start date

2017-08-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who are cryptozoospermia or asthenozoospermia which has less effective treatments besides ICSI or who meet criteria listed below in last two sperm inspections; 1) Cryptozoospermia meet at least one as follows; -Total sperm concentration is not more than 1000 x 10^4/ml. -Active sperm concentration is not more than 500 x 10^4/ml. 2) Asthenozoospermia Sperm motility is not more than 20%.

Exclusion criteria

Exclusion criteria: 1) Patients with a previous/ current history of severe disease (malignant tumor, heart disease, kidney disease and liver disease) 2) Patients who have experienced severe allergic reaction to foods and pharmaceutical products. 3) Patients whom doctors judge to be unsuitable for this study.

Design outcomes

Primary

Measure	Time frame
Sperm views (sperm concentration, sperm motility, linearity, high speed progressive motility, progressive motility)	—

Countries

Japan

Contacts

Public ContactKohyu Furuhashi

Hanabusa Women's Clinic Division of Embryo

furuhashi@hanabusaclinic.com078-392-8716

Outcome results